Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03132454
Title Study of Palbociclib Alone and in Combination in Patients With Relapsed and Refractory (R/R) Leukemias
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center

acute lymphoblastic leukemia

acute myeloid leukemia


Decitabine + Palbociclib

Dexamethasone + Palbociclib


Palbociclib + Sorafenib

Age Groups: adult | child | senior
Covered Countries USA

No variant requirements are available.